ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 30 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $168,000 | -34.4% | 284,285 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $256,000 | -30.8% | 284,285 | 0.0% | 0.01% | -33.3% |
Q2 2021 | $370,000 | -6.3% | 284,285 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $395,000 | +8.5% | 284,285 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $364,000 | -13.5% | 284,285 | 0.0% | 0.01% | -31.6% |
Q3 2020 | $421,000 | -6.2% | 284,285 | 0.0% | 0.02% | -17.4% |
Q2 2020 | $449,000 | +63.9% | 284,285 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $274,000 | -85.7% | 284,285 | -41.6% | 0.02% | -59.6% |
Q3 2019 | $1,919,000 | -40.2% | 486,978 | -38.3% | 0.06% | -6.6% |
Q2 2019 | $3,211,000 | -68.7% | 788,958 | -46.1% | 0.06% | -73.1% |
Q1 2019 | $10,272,000 | +6.6% | 1,463,208 | -17.2% | 0.23% | -11.3% |
Q4 2018 | $9,636,000 | -49.3% | 1,768,104 | -0.0% | 0.26% | -7.9% |
Q3 2018 | $18,994,000 | -16.2% | 1,768,568 | +1.7% | 0.28% | -21.7% |
Q2 2018 | $22,670,000 | +48.7% | 1,739,805 | +18.8% | 0.36% | +14.5% |
Q1 2018 | $15,241,000 | +15.0% | 1,463,894 | -0.0% | 0.31% | -1.3% |
Q4 2017 | $13,255,000 | – | 1,464,204 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $2,518,000 | 11.16% |
AIGH Capital Management LLC | 4,000,000 | $3,608,000 | 0.76% |
Worth Venture Partners, LLC | 980,200 | $884,000 | 0.40% |
Altium Capital Management LP | 1,067,886 | $963,000 | 0.25% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $3,005,000 | 0.24% |
Golden Green, Inc. | 33,000 | $30,000 | 0.02% |
LEVEL FOUR FINANCIAL, LLC | 40,000 | $36,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 152,731 | $138,000 | 0.01% |
PFM Health Sciences, LP | 284,285 | $256,000 | 0.01% |
XTX Topco Ltd | 21,443 | $19,000 | 0.01% |